Annual Total Long Term Liabilities
$87.57 M
-$9.49 M-9.78%
31 December 2023
Summary:
C4 Therapeutics annual total long term liabilities is currently $87.57 million, with the most recent change of -$9.49 million (-9.78%) on 31 December 2023. During the last 3 years, it has risen by +$12.08 million (+16.00%). CCCC annual total long term liabilities is now -56.71% below its all-time high of $202.29 million, reached on 31 December 2018.CCCC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$90.11 M
+$10.28 M+12.87%
30 September 2024
Summary:
C4 Therapeutics quarterly total long term liabilities is currently $90.11 million, with the most recent change of +$10.28 million (+12.87%) on 30 September 2024. Over the past year, it has increased by +$3.39 million (+3.91%). CCCC quarterly long term liabilities is now -73.88% below its all-time high of $345.04 million, reached on 30 September 2020.CCCC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.8% | +3.9% |
| 3 y3 years | +16.0% | +49.1% |
| 5 y5 years | -56.7% | - |
CCCC Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.8% | +32.9% | -13.3% | +49.1% |
| 5 y | 5 years | -56.7% | +32.9% | -73.9% | +49.1% |
| alltime | all time | -56.7% | +32.9% | -73.9% | +49.1% |
C4 Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $90.11 M(+12.9%) |
| June 2024 | - | $79.83 M(-6.2%) |
| Mar 2024 | - | $85.07 M(-2.9%) |
| Dec 2023 | $87.57 M(-9.8%) | $87.57 M(+1.0%) |
| Sept 2023 | - | $86.72 M(-6.8%) |
| June 2023 | - | $93.06 M(-1.2%) |
| Mar 2023 | - | $94.19 M(-3.0%) |
| Dec 2022 | $97.06 M | $97.06 M(-1.0%) |
| Sept 2022 | - | $97.99 M(-3.7%) |
| June 2022 | - | $101.73 M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $103.97 M(+57.7%) |
| Dec 2021 | $65.91 M(-12.7%) | $65.91 M(+9.0%) |
| Sept 2021 | - | $60.44 M(-10.9%) |
| June 2021 | - | $67.83 M(-6.6%) |
| Mar 2021 | - | $72.65 M(-3.8%) |
| Dec 2020 | $75.50 M(-61.6%) | $75.50 M(-78.1%) |
| Sept 2020 | - | $345.04 M(+286.9%) |
| June 2020 | - | $89.17 M(-54.6%) |
| Dec 2019 | $196.58 M(-2.8%) | $196.58 M |
| Dec 2018 | $202.29 M | - |
FAQ
- What is C4 Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for C4 Therapeutics?
- What is C4 Therapeutics annual total long term liabilities year-on-year change?
- What is C4 Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for C4 Therapeutics?
- What is C4 Therapeutics quarterly long term liabilities year-on-year change?
What is C4 Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CCCC is $87.57 M
What is the all time high annual total long term liabilities for C4 Therapeutics?
C4 Therapeutics all-time high annual total long term liabilities is $202.29 M
What is C4 Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CCCC annual total long term liabilities has changed by -$9.49 M (-9.78%)
What is C4 Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CCCC is $90.11 M
What is the all time high quarterly long term liabilities for C4 Therapeutics?
C4 Therapeutics all-time high quarterly total long term liabilities is $345.04 M
What is C4 Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CCCC quarterly total long term liabilities has changed by +$3.39 M (+3.91%)